Treatment for Glaucoma and Altitude Sickness Could Slow the Progression of Glioblastoma
Pexels / Pixabay

Treatment for Glaucoma and Altitude Sickness Could Slow the Progression of Glioblastoma

According to a story from EurekAlert!, researchers have found that the drug Diamox, which is used to treat a variety of illnesses and conditions such as altitude sickness, glaucoma, epilepsy,…

Continue Reading Treatment for Glaucoma and Altitude Sickness Could Slow the Progression of Glioblastoma
New Drug Approved in the EU for Treating Hereditary Transthyretin Amyloidosis
Source: Pixabay.com

New Drug Approved in the EU for Treating Hereditary Transthyretin Amyloidosis

According to a story from bioportfolio.com, two companies, Ionis Pharmaceuticals, Inc., and its affiliate Akcea Pharmaceuticals, recently announced that its product inotersen (to be marketed as TEGSEDI) has gained approval…

Continue Reading New Drug Approved in the EU for Treating Hereditary Transthyretin Amyloidosis
An Experimental Drug For Treating Duchenne Muscular Dystrophy Will be Studied in a Phase 3 Trial, Catabasis Says
stevepb / Pixabay

An Experimental Drug For Treating Duchenne Muscular Dystrophy Will be Studied in a Phase 3 Trial, Catabasis Says

Catabasis Pharmaceuticals Inc. has announced plans for a Phase 3 clinical trial called Polaris DMD. It will investigate the experimental drug edasalonexent for the treatment of patients with Duchenne muscular…

Continue Reading An Experimental Drug For Treating Duchenne Muscular Dystrophy Will be Studied in a Phase 3 Trial, Catabasis Says
How Rare is Eosinophilic Esophagitis Anyway? A Family’s Story Brings Awareness
White77 / Pixabay

How Rare is Eosinophilic Esophagitis Anyway? A Family’s Story Brings Awareness

According to a story from the Washington Times-Reporter, Michelle Marcinak's three sons-- John Henry, Leo, and Rafe-- were all diagnosed with the rare gastric condition eosinophilic esophagitis. Early symptoms of…

Continue Reading How Rare is Eosinophilic Esophagitis Anyway? A Family’s Story Brings Awareness
Investigational Drug for Facioscapulohumeral Muscular Dystrophy Gets Orphan Drug Designation
simple_tunchi0 / Pixabay

Investigational Drug for Facioscapulohumeral Muscular Dystrophy Gets Orphan Drug Designation

According to a story from BioSpace, the biopharmaceutical company Acceleron Pharma, which develops TGF-beta based treatments for rare and serious illnesses, recently announced that the U.S. Food and Drug Administration…

Continue Reading Investigational Drug for Facioscapulohumeral Muscular Dystrophy Gets Orphan Drug Designation
Kids With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Experience Complications and Get Inconsistent Treatment, Study Says
RachelBostwick / Pixabay

Kids With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Experience Complications and Get Inconsistent Treatment, Study Says

According to a story from ScienceDaily, a recent analysis has been conducted in order to investigate patient outcomes for children with the rare skin condition Stevens-Johnson syndrome, as well its…

Continue Reading Kids With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Experience Complications and Get Inconsistent Treatment, Study Says

Priority Review Granted to an Investigational Treatment for Acute Myeloid Leukaemia

The US Food and Drug Administration (FDA) has awarded Priority Review Designation to glasdegib, an experimental drug designed as a treatment for previously untreated acute myeloid leukaemia in combination with…

Continue Reading Priority Review Granted to an Investigational Treatment for Acute Myeloid Leukaemia
Close Menu